C4 Therapeutics, Inc. (CCCC) insider trading

By person

10 insiders · 2 transactions

3.4×

Andrew J. Hirsch holds only 3.4 times base salary in stock. $2.39M of shares against $694.93K in salary for 2025.

Salary from the company's own proxy. The shares are what Andrew J. Hirsch last reported holding, valued at $2.22, the price Common Stock was last bought or sold at on the open market here, on 16 Jan 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Leonard Reyno

Chief Medical Officer

—

$22.20K (1)

−$22.20K

372,406

0.3027%

$826.74K

+717.9%

Andrew Hirsch

President & CEO

—

1,074,934

0.8738%

$2.39M

+853.1%

Kendra Adams

Chief Financial Officer

—

382,323

0.3108%

$848.76K

+1,005%

Kenneth Carl Anderson

Director

—

361,897

0.2942%

$803.41K

+12.9%

Paige Mahaney

Chief Scientific Officer

—

336,910

0.2739%

$747.94K

+566.5%

Kelly Schick

Chief People Officer

—

299,881

0.2438%

$665.74K

+975.2%

Scott N Boyle

Chief Business Officer

—

298,801

0.2429%

$663.34K

+968.3%

Jolie Siegel

Chief Legal Officer

—

107,939

0.0877%

$239.62K

+100.5%

Donna Roy Grogan

Director

—

79,471

0.0646%

$176.43K

+174.6%

Mark Mossler

Chief Accounting Officer

—

71,916

0.0585%

$159.65K

+593.5%

C4 Therapeutics, Inc.

What the insiders did Net selling

By person